$21.99
3M Ago | 1M Ago | Current | |
Buy | 13 | 12 | 11 |
Outperform | 8 | 8 | 8 |
Hold | 3 | 3 | 3 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Denali Therapeutics Inc (DNLI) is $56.86, offered by 22 analysts offering 12-month price forecasts.
Denali Therapeutics Inc (DNLI) has a maximum of 1.59 upside potential, based on 22 analysts offering 12-month price forecasts.
Based on 22 analysts tracking and researching Denali Therapeutics Inc (DNLI), 86.36% have a buy recommendation. Remaining 13.64% have either sell or hold recommendations.
The latest share price of Denali Therapeutics Inc (DNLI) is $21.99 as of 27/09/2023.
19 of total 22 analysts offering stock ratings for Denali Therapeutics Inc DNLI have recommended buy rating.